InsidersTradesSigma
마크로젠 Stock: price and directors' dealings · South Korea · DART (FSS)
Track the 마크로젠 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 마크로젠 has logged 127 reports. Market capitalisation: €134.5bn. The latest transaction was disclosed on 25 June 2026 (Other). Among the most active insiders: 김창훈. The full history is accessible without an account.
127
Insider Decl.
0
Thresholds
·
3 ops.
Buy Volume
·
2 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 19,273 of 25,514 companies
34.2
score / 100
Value35
Quality33
FCF yld-10%
Earn yld1.6%
EV/EBITDA11.7x
ROE·
Gross mgn36%
Net mgn1.0%
Debt/EBITDA5.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 25 June 2026
Declarations127 total
25 of 127 declarations
About 마크로젠
마크로젠 is a company specializing in the health and pharmaceutical sector, listed on the XKRX market. It focuses on genomic and biotechnology services.